NICE guidelines for type 2 diabetes (NG28) recommend reviewing GLP-1 treatment at around 6 months and continuing only if there has been a meaningful reduction in HbA1c (typically at least 11 mmol/mol [1%]) and weight loss of at least 3% of initial body weight
metabolic antagonist)
GLP-1 weight loss medications, such as Wegovy, Ozempic, Mounjaro, Zepbound, and semaglutide, are not just promising in their potential to combat obesity but also in their market growth
By your thirties, you should consider adding in a retinol into your skin care regimen to help combat the slowing down of collagen and elastin production
Regular nutritional blood panel monitoring allows these deficiencies to be caught and corrected before they become clinically significant
Without coverage, Zepbound's list price is ~$1,086/month, though TrumpRx.gov (~$346/mo) and LillyDirect ($299-449/mo) offer lower self-pay options